Modulation of tumor immunity by therapeutic monoclonal antibodies

ISSN： 0167-7659

Source： Cancer and Metastasis Reviews, Vol.30, Iss.1, 2011-03, pp. : 111-124

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Infusion Reactions Associated with the Therapeutic Use of Monoclonal Antibodies in the Treatment of Malignancy

By Dillman R.O.

Cancer and Metastasis Reviews, Vol. 18, Iss. 4, 1999-12 ,pp. : 465-471

Springer Publishing Company

Access to resources Recommend Favorite

Novel monoclonal antibodies specific for CTLD-SSC and sialomucin domains of endosialin, a mural cell marker of tumor vasculature

International Journal of Oncology, Vol. 41, Iss. 4, 2012-01 ,pp. : 1365-1372

Spandidos Publications

Access to resources Recommend Favorite

Role of antibody-dependent cell-mediated cytotoxicity in the efficacy of therapeutic anti-cancer monoclonal antibodies

By Iannello Alexandre Ahmad Ali

Cancer and Metastasis Reviews, Vol. 24, Iss. 4, 2005-12 ,pp. : 487-499

Springer Publishing Company

Access to resources Recommend Favorite

Monoclonal antibodies targeting the VEGF receptor-2 (Flk1/KDR) as an anti-angiogenic therapeutic strategy

By Witte L.

Cancer and Metastasis Reviews, Vol. 17, Iss. 2, 1998-06 ,pp. : 155-161

Springer Publishing Company

Access to resources Recommend Favorite

Monoclonal Antibodies in Clinical Oncology

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 8, Iss. 5, 2008-06 ,pp. : 523-532

Bentham Science Publishers

Access to resources Recommend Favorite